Aurora Cannabis falls despite upbeat Q4 results as sales forecast weighs

U.S.-listed shares of pot firm Aurora Cannabis ACB.TO, ACB.O down 13.6% at $5.08 premarket

ACB forecasts global cannabis revenue to be slightly lower in Q1 2026 vs Q4 2025 due to temporary decline in some international markets

Posts Q4 net revenue of C$90.5 million vs est. of C$88.82 million - data compiled by LSEG

Company reports Q4 adjusted core profit of C$16.7 million vs C$2.32 million a year ago

Company says it found error in inventory and cost of sales from intercompany profit eliminations in financial statements for year ended March 31, 2025

ACB adds that financial statement errors are not material to any of its previously issued financial statements

Up till last close, stock up 38.4% YTD